谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Englumafusp Alfa (CD19-4-1BBL) Combined with Glofitamab is Safe and Efficacious in Patients with R/r B-NHL: Extended Follow Up Analysis of the Dose-Escalation Part of Phase 1 Trial BP41072
Martin Hutchings, Michael J. Dickinson,Giuseppe Gritti, Carmelo Carlo-Stella, William Townsend, Francesc Bosch, Nancy L. Bartlett, Guillaume Cartron,Herve Ghesquieres,Roch Houot, Harriet S. Walter,Fritz Offner,Natalie Dimier,Candice Jamois, Lance Smith, Sylvia Herter,Denis Sahin, Abiraj Keelara,Koorosh Korfi, Jeremy Gallien, Marie-Helene Wasmer,Heather Hinton, Matt Whayman, Isabel Prieto, Georgios Kazantzidis,Katharina Lechner,Franck Morschhauser
Bloodno. Supplement 1 (2024): 990-990
引用0浏览0引用
0
0
CD19-CD28 (RO7443904) Combination with Glofitamab Enhances T-Cell Proliferation and Effector Function in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL)
Koorosh Korfi,Sabine Wilson, Zhiwen Jiang, Ailsa Christiansen, Sreenath Krishnan,Candice Jamois,Annika Blank,Alexandra Epp, Abraham Silva, Philip Knuckles, Joanne Hayward,Johannes Sam,Katharina Lechner,Natalie Dimier, Paolo F. Caimi, Lorenzo Falchi,Giuseppe Gritti,Franck Morschhauser,Martin Hutchings, Michael J. Dickinson, Carmelo Carlo-Stella
Bloodno. Supplement 1 (2024): 644-644
引用0浏览0引用
0
0
BP43131, a Phase 1 Dose Escalation Study: CD19 Targeted CD28 Costimulatory Agonist (RO7443904) Combined with Glofitamab Shows Promising Efficacy in Patients with Relapsed/Refractory Aggressive B-NHL
Michael J. Dickinson, Martin Hutchings,Franck Morschhauser, Carmelo Carlo-Stella, Lorenzo Falchi, Paolo F. Caimi,Natalie Dimier, Lance Smith, Matt Whayman,Johannes Sam, Abiraj Keelara,Koorosh Korfi,Candice Jamois, Jeremy Gallien, Nicole Martin, Iris Martinez Quetglas,Heather Hinton, Isabel Prieto,Francesca Michielin,Katharina Lechner,Giuseppe Gritti
Bloodno. Supplement 1 (2024): 3123-3123
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 0

#Citation: 0

H-Index: 0

G-Index: 0

Sociability: 0

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn